Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Foralivit is an oral multivitamin and iron supplement formulated as a capsule. It contains a combination of ferrous sulfate heptahydrate (providing elemental iron), folic acid (vitamin B9), thiamine mononitrate (vitamin B1), riboflavin (vitamin B2), pyridoxine hydrochloride (vitamin B6), and cyanocobalamin (vitamin B12). Developed and distributed by Eurocare Pharma in the Philippines, Foralivit is indicated for the prevention and treatment of iron deficiency anemia and vitamin B complex deficiencies, and is commonly utilized as a prenatal hematinic to support the increased nutritional demands during pregnancy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Foralivit.